Cargando…
How promising is phototherapy for cancer?
Oncological phototherapy, including current photodynamic therapy (PDT), developmental photoactivated chemotherapy (PACT) and photothermal therapy (PTT), shows promising photo-efficacy for superficial and internal tumours. The dual application of light and photochemotherapeutic agents allows accurate...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492227/ https://www.ncbi.nlm.nih.gov/pubmed/32587359 http://dx.doi.org/10.1038/s41416-020-0926-3 |
_version_ | 1783582346250813440 |
---|---|
author | Shi, Huayun Sadler, Peter J. |
author_facet | Shi, Huayun Sadler, Peter J. |
author_sort | Shi, Huayun |
collection | PubMed |
description | Oncological phototherapy, including current photodynamic therapy (PDT), developmental photoactivated chemotherapy (PACT) and photothermal therapy (PTT), shows promising photo-efficacy for superficial and internal tumours. The dual application of light and photochemotherapeutic agents allows accurate cancer targeting, low invasiveness and novel mechanisms of action. Current advances in new light sources and photoactive agents are encouraging for future development. |
format | Online Article Text |
id | pubmed-7492227 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-74922272020-10-01 How promising is phototherapy for cancer? Shi, Huayun Sadler, Peter J. Br J Cancer Comment Oncological phototherapy, including current photodynamic therapy (PDT), developmental photoactivated chemotherapy (PACT) and photothermal therapy (PTT), shows promising photo-efficacy for superficial and internal tumours. The dual application of light and photochemotherapeutic agents allows accurate cancer targeting, low invasiveness and novel mechanisms of action. Current advances in new light sources and photoactive agents are encouraging for future development. Nature Publishing Group UK 2020-06-26 2020-09-15 /pmc/articles/PMC7492227/ /pubmed/32587359 http://dx.doi.org/10.1038/s41416-020-0926-3 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Comment Shi, Huayun Sadler, Peter J. How promising is phototherapy for cancer? |
title | How promising is phototherapy for cancer? |
title_full | How promising is phototherapy for cancer? |
title_fullStr | How promising is phototherapy for cancer? |
title_full_unstemmed | How promising is phototherapy for cancer? |
title_short | How promising is phototherapy for cancer? |
title_sort | how promising is phototherapy for cancer? |
topic | Comment |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492227/ https://www.ncbi.nlm.nih.gov/pubmed/32587359 http://dx.doi.org/10.1038/s41416-020-0926-3 |
work_keys_str_mv | AT shihuayun howpromisingisphototherapyforcancer AT sadlerpeterj howpromisingisphototherapyforcancer |